CFA
Camarda Financial Advisors Portfolio holdings
AUM
$254M
This Quarter Return
+0.72%
1 Year Return
+25.59%
3 Year Return
+123.34%
5 Year Return
+275.65%
10 Year Return
+350.86%
AUM
$95.2M
AUM Growth
+$95.2M
(-1.6%)
Cap. Flow
-$1.47M
Cap. Flow
% of AUM
-1.55%
Top 10 Holdings %
Top 10 Hldgs %
54.37%
Holding
195
New
26
Increased
26
Reduced
52
Closed
12
Top Buys
| 1 |
Snap-on
SNA
|
$977K |
| 2 |
Biogen
BIIB
|
$889K |
| 3 |
Louisiana-Pacific
LPX
|
$853K |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$137K |
| 5 |
Alerian MLP ETF
AMLP
|
$117K |
Top Sells
| 1 |
MSGN
MSG Networks Inc.
MSGN
|
$1.29M |
| 2 |
TWX
Time Warner Inc
TWX
|
$1.13M |
| 3 |
TEGNA Inc
TGNA
|
$1.05M |
| 4 |
Usana Health Sciences
USNA
|
$264K |
| 5 |
KKR & Co
KKR
|
$168K |
Sector Composition
| 1 | Industrials | 11.14% |
| 2 | Healthcare | 8.55% |
| 3 | Consumer Discretionary | 8.27% |
| 4 | Technology | 7.67% |
| 5 | Financials | 3.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Invesco Senior Loan ETF
BKLN
$6.97B
| $12.6M | 13.26% | 550,945 +3,116 | +0.6% | +$71.4K |
|
2
Invesco Preferred ETF
PGX
$3.85B
| $10.3M | 10.8% | 706,097 +2,564 | +0.4% | +$37.3K |
|
3
iShares Select Dividend ETF
DVY
$20.8B
| $7.35M | 7.72% | 75,149 -102 | -0.1% | -$9.97K |
|
|
4
Alerian MLP ETF
AMLP
$10.7B
| $6.95M | 7.3% | 687,906 +11,621 | +2% | +$117K |
|
5
iShares International Select Dividend ETF
IDV
$5.77B
| $5.74M | 6.03% | 179,086 +169 | +0.1% | +$5.42K |
|
|
6
Usana Health Sciences
USNA
$583M
| $2.11M | 2.22% | 18,325 -2,286 | -11% | -$264K |
|
7
Apple
AAPL
$3.45T
| $2.1M | 2.21% | 11,355 -224 | -2% | -$41.5K |
|
8
Lear
LEA
$5.85B
| $1.74M | 1.83% | 9,361 -645 | -6% | -$120K |
|
9
Robert Half
RHI
$3.8B
| $1.45M | 1.52% | 22,215 -2,526 | -10% | -$164K |
|
10
Ross Stores
ROST
$48.1B
| $1.41M | 1.48% | 16,631 -1,790 | -10% | -$152K |
|
11
HP
HPQ
$26.7B
| $1.29M | 1.36% | 56,897 -5,957 | -9% | -$135K |
|
12
SPDR Bloomberg High Yield Bond ETF
JNK
$8.1B
| $1.25M | 1.32% | 35,324 -3,845 | -10% | -$136K |
|
|
GAP
13
The Gap, Inc.
GAP
$8.21B
| $1.22M | 1.29% | 37,789 -3,615 | -9% | -$117K |
|
14
Bristol-Myers Squibb
BMY
$96B
| $1.19M | 1.25% | 21,531 | – | – |
|
15
Innoviva
INVA
$1.29B
| $1.11M | 1.17% | 80,609 -7,735 | -9% | -$107K |
|
16
Lam Research
LRCX
$127B
| $1.09M | 1.14% | 6,275 -683 | -10% | -$118K |
|
17
Applied Materials
AMAT
$128B
| $1.08M | 1.13% | 23,383 -2,461 | -10% | -$114K |
|
|
SP
18
DELISTED
SP Plus Corporation
SP
| $1.05M | 1.1% | 28,234 -2,646 | -9% | -$98.4K |
|
19
Deluxe
DLX
$882M
| $1.03M | 1.09% | 15,612 -1,599 | -9% | -$106K |
|
20
Gilead Sciences
GILD
$140B
| $1M | 1.05% | 14,159 -362 | -2% | -$25.6K |
|
|
21
Snap-on
SNA
$17B
| $977K | 1.03% | +6,078 | New | +$977K |
|
|
MIK
22
DELISTED
Michaels Stores, Inc
MIK
| $975K | 1.02% | 50,851 -4,733 | -9% | -$90.7K |
|
23
Merck
MRK
$210B
| $965K | 1.01% | 15,904 | – | – |
|
24
Wabash National
WNC
$454M
| $933K | 0.98% | 50,018 -4,713 | -9% | -$87.9K |
|
25
Pfizer
PFE
$141B
| $909K | 0.96% | 25,052 -321 | -1% | -$11.6K |
|